School of Medicine
Showing 1-6 of 6 Results
-
Saad A. Khan, MD
Assistant Professor of Medicine (Oncology) at the Stanford University Medical Center
Bio Saad A. Khan, MD is a medical oncologist focused on the treatment of head and neck, thyroid and lung cancers. His research interests include therapeutic clinical trials as well as mechanisms of reducing toxicities that patients experience. His research activities include ongoing clinical trials of targeted and immune therapy in aggressive thyroid malignancies. He is a member of the NRG Head and Neck Committee, the ECOG Head and Neck Core and Thoracic Committees and the National Cancer Institute?s Head and Neck Steering Committee Rare Tumor Task Force.
When not in clinic or the hospital he enjoys spending time with his family and 3 children, hiking and sitting on the beach. -
Youn H Kim, MD
The Joanne and Peter Haas, Jr., Professor for Cutaneous Lymphoma Research and Professor, by courtesy, of Medicine (Oncology) at the Stanford University Medical Center
Current Research and Scholarly Interests Clinical research in cutaneous lymphomas, especially, mycosis fungoides; studies of prognostic factors, long-term survival results, and effects of therapies. Collaborative research with Departments of Pathology and Oncology in basic mechanisms of cutaneous lymphomas. Clinical trials of new investigative therapies for various dermatologic conditions or clinical trials of known therapies for new indications.
-
Allison W. Kurian, M.D., M.Sc.
Professor of Medicine (Oncology) and of Epidemiology and Population Health at the Stanford University Medical Center
Current Research and Scholarly Interests I aim to improve the outcomes of women's cancers through clinically-oriented research on genetic risk assessment, risk-adapted screening and prevention.
-
David Kurtz
Instructor, Medicine - Oncology
Current Research and Scholarly Interests Implementation of noninvasive detection of malignancies in the clinic remains difficult due to both technical and clinical challenges. These include necessary improvements in sensitivity and specificity of biomarkers, as well as demonstration of clinical utility of these assays. My research focuses on technical development and implementation of assays to detect and track cancers in order to facilitate personalized disease management.
